請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37345完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 吳美玲 | |
| dc.contributor.author | Yu-Ting Hsiao | en |
| dc.contributor.author | 蕭育婷 | zh_TW |
| dc.date.accessioned | 2021-06-13T15:25:04Z | - |
| dc.date.available | 2013-08-08 | |
| dc.date.copyright | 2008-08-08 | |
| dc.date.issued | 2008 | |
| dc.date.submitted | 2008-07-18 | |
| dc.identifier.citation | Alley, M. C., Uhl, C. B., and Lieber, M. M. (1982). Improved detection of drug cytotoxicity in the soft agar colony formation assay through use of a metabolizable tetrazolium salt. Life Sci 31, 3071-3078.
Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. (1988). Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549-554. Ankarcrona, M., Dypbukt, J. M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S. A., and Nicotera, P. (1995). Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973. Apffel, C. A., Arnason, B. G., and Peters, J. H. (1966). Induction of tumour immunity with tumour cells treated with iodoacetate. Nature 209, 694-696. Arcari, P., Martinelli, R., and Salvatore, F. (1984). The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. Nucleic Acids Res 12, 9179-9189. Arnoult, D., Gaume, B., Karbowski, M., Sharpe, J. C., Cecconi, F., and Youle, R. J. (2003). Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J 22, 4385-4399. Arutyunova, E. I., Danshina, P. V., Domnina, L. V., Pleten, A. P., and Muronetz, V. I. (2003). Oxidation of glyceraldehyde-3-phosphate dehydrogenase enhances its binding to nucleic acids. Biochem Biophys Res Commun 307, 547-552. Beevers, H., and Simon, E. W. (1949). Effect of pH on the activity of some respiratory inhibitors. Nature 163, 408. Beisswenger, P. J., Howell, S. K., Smith, K., and Szwergold, B. S. (2003). Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochim Biophys Acta 1637, 98-106. Berk, M., Ng, F., Dean, O., Dodd, S., and Bush, A. I. (2008). Glutathione: a novel treatment target in psychiatry. Trends Pharmacol Sci. Berrington de Gonzalez, A., Sweetland, S., and Spencer, E. (2003). A meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 89, 519-523. Bickis, I. J., and Quastel, J. H. (1965). Effects of Metabolic Inhibitors on Energy Metabolism of Ehrlich Ascites Carcinoma Cells. Nature 205, 44-46. Biedermann, K. A., and Landolph, J. R. (1987). Induction of anchorage independence in human diploid foreskin fibroblasts by carcinogenic metal salts. Cancer Res 47, 3815-3823. Borst, P., Evers, R., Kool, M., and Wijnholds, J. (1999). The multidrug resistance protein family. Biochim Biophys Acta 1461, 347-357. Boschman, C. R., Stryker, S., Reddy, J. K., and Rao, M. S. (1994). Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas. Am J Pathol 145, 1291-1295. Brownlee, M., Cerami, A., and Vlassara, H. (1988). Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318, 1315-1321. Brummelkamp, T. R., Bernards, R., and Agami, R. (2002). A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553. Brune, B., and Lapetina, E. G. (1996). Nitric oxide-induced covalent modification of glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase. Methods Enzymol 269, 400-407. Burke, J. R., Enghild, J. J., Martin, M. E., Jou, Y. S., Myers, R. M., Roses, A. D., Vance, J. M., and Strittmatter, W. J. (1996). Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 2, 347-350. Burris, H. A., 3rd, Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997). Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15, 2403-2413. Cain, K., Bratton, S. B., and Cohen, G. M. (2002). The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie 84, 203-214. Caldas, C., Hahn, S. A., da Costa, L. T., Redston, M. S., Schutte, M., Seymour, A. B., Weinstein, C. L., Hruban, R. H., Yeo, C. J., and Kern, S. E. (1994). Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8, 27-32. Campbell, S. L., Khosravi-Far, R., Rossman, K. L., Clark, G. J., and Der, C. J. (1998). Increasing complexity of Ras signaling. Oncogene 17, 1395-1413. Chang, W. H., Chen, C. H., and Lu, F. J. (2002). Different effects of baicalein, baicalin and wogonin on mitochondrial function, glutathione content and cell cycle progression in human hepatoma cell lines. Planta Med 68, 128-132. Chatterjee, S., Noack, H., Possel, H., Keilhoff, G., and Wolf, G. (1999). Glutathione levels in primary glial cultures: monochlorobimane provides evidence of cell type-specific distribution. Glia 27, 152-161. Chien, K. R., Sen, A., Reynolds, R., Chang, A., Kim, Y., Gunn, M. D., Buja, L. M., and Willerson, J. T. (1985). Release of arachidonate from membrane phospholipids in cultured neonatal rat myocardial cells during adenosine triphosphate depletion. Correlation with the progression of cell injury. J Clin Invest 75, 1770-1780. Chuang, D. M., Hough, C., and Senatorov, V. V. (2005). Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. Annu Rev Pharmacol Toxicol 45, 269-290. Colell, A., Ricci, J. E., Tait, S., Milasta, S., Maurer, U., Bouchier-Hayes, L., Fitzgerald, P., Guio-Carrion, A., Waterhouse, N. J., Li, C. W., et al. (2007). GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell 129, 983-997. Concin, N., Stimpfl, M., Zeillinger, C., Wolff, U., Hefler, L., Sedlak, J., Leodolter, S., and Zeillinger, R. (2003). Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines. Int J Oncol 22, 51-57. Cook, J. A., Iype, S. N., and Mitchell, J. B. (1991). Differential specificity of monochlorobimane for isozymes of human and rodent glutathione S-transferases. Cancer Res 51, 1606-1612. Cramer, T., Yamanishi, Y., Clausen, B. E., Forster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003). HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112, 645-657. Crompton, M. (1999). The mitochondrial permeability transition pore and its role in cell death. Biochem J 341 ( Pt 2), 233-249. Cuezva, J. M., Chen, G., Alonso, A. M., Isidoro, A., Misek, D. E., Hanash, S. M., and Beer, D. G. (2004). The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis 25, 1157-1163. Darzynkiewicz, Z., Bruno, S., Del Bino, G., Gorczyca, W., Hotz, M. A., Lassota, P., and Traganos, F. (1992). Features of apoptotic cells measured by flow cytometry. Cytometry 13, 795-808. Davis, W., Jr., Ronai, Z., and Tew, K. D. (2001). Cellular thiols and reactive oxygen species in drug-induced apoptosis. J Pharmacol Exp Ther 296, 1-6. Dergham, S. T., Dugan, M. C., Kucway, R., Du, W., Kamarauskiene, D. S., Vaitkevicius, V. K., Crissman, J. D., and Sarkar, F. H. (1997). Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma. Int J Pancreatol 21, 127-143. DiGiuseppe, J. A., Hruban, R. H., Goodman, S. N., Polak, M., van den Berg, F. M., Allison, D. C., Cameron, J. L., and Offerhaus, G. J. (1994). Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 101, 684-688. Du, C., Fang, M., Li, Y., Li, L., and Wang, X. (2000). Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42. Du, Z. X., Wang, H. Q., Zhang, H. Y., and Gao, D. X. (2007). Involvement of glyceraldehyde-3-phosphate dehydrogenase in tumor necrosis factor-related apoptosis-inducing ligand-mediated death of thyroid cancer cells. Endocrinology 148, 4352-4361. Eley, D. W., Eley, J. M., Korecky, B., and Fliss, H. (1991). Impairment of cardiac contractility and sarcoplasmic reticulum Ca2+ ATPase activity by hypochlorous acid: reversal by dithiothreitol. Can J Physiol Pharmacol 69, 1677-1685. Epner, D. E., Partin, A. W., Schalken, J. A., Isaacs, J. T., and Coffey, D. S. (1993). Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma. Cancer Res 53, 1995-1997. Epner, D. E., Sawa, A., and Isaacs, J. T. (1999). Glyceraldehyde-3-phosphate dehydrogenase expression during apoptosis and proliferation of rat ventral prostate. Biol Reprod 61, 687-691. Everhart, J., and Wright, D. (1995). Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA 273, 1605-1609. Fahim, F. A., Esmat, A. Y., Mady, E. A., and Ibrahim, E. K. (2003). Antitumor activities of iodoacetate and dimethylsulphoxide against solid Ehrlich carcinoma growth in mice. Biol Res 36, 253-262. Flanagan, R. J., and Meredith, T. J. (1991). Use of N-acetylcysteine in clinical toxicology. Am J Med 91, 131S-139S. Fleming, J. B., Shen, G. L., Holloway, S. E., Davis, M., and Brekken, R. A. (2005). Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy. Mol Cancer Res 3, 413-423. Ford, H. L., and Pardee, A. B. (1999). Cancer and the cell cycle. J Cell Biochem Suppl 32-33, 166-172. Fuchs, C. S., Colditz, G. A., Stampfer, M. J., Giovannucci, E. L., Hunter, D. J., Rimm, E. B., Willett, W. C., and Speizer, F. E. (1996). A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 156, 2255-2260. Gallis, J. L., Tissier, P., Gin, H., and Beauvieux, M. C. (2007). Decrease in oxidative phosphorylation yield in presence of butyrate in perfused liver isolated from fed rats. BMC Physiol 7, 8. Gapstur, S. M., Gann, P. H., Lowe, W., Liu, K., Colangelo, L., and Dyer, A. (2000). Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 283, 2552-2558. Genini, D., Budihardjo, I., Plunkett, W., Wang, X., Carrera, C. J., Cottam, H. B., Carson, D. A., and Leoni, L. M. (2000). Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway. J Biol Chem 275, 29-34. Gong, Y., Cui, L., and Minuk, G. Y. (1996). Comparison of glyceraldehyde-3-phosphate dehydrogenase and 28s-ribosomal RNA gene expression in human hepatocellular carcinoma. Hepatology 23, 734-737. Green, D. R., and Reed, J. C. (1998). Mitochondria and apoptosis. Science 281, 1309-1312. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54, 4855-4878. Gunn, M. D., Sen, A., Chang, A., Willerson, J. T., Buja, L. M., and Chien, K. R. (1985). Mechanisms of accumulation of arachidonic acid in cultured myocardial cells during ATP depletion. Am J Physiol 249, H1188-1194. Hara, M. R., Cascio, M. B., and Sawa, A. (2006). GAPDH as a sensor of NO stress. Biochim Biophys Acta 1762, 502-509. Hara, M. R., Agrawal, N., Kim, S. F., Cascio, M. B., Fujimuro, M., Ozeki, Y., Takahashi, M., Cheah, J. H., Tankou, S. K., Hester, L. D., et al. (2005). S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol 7, 665-674. Hatcher, H., Planalp, R., Cho, J., Torti, F. M., and Torti, S. V. (2008). Curcumin: From ancient medicine to current clinical trials. Cell Mol Life Sci 65, 1631-1652. Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., and Depinho, R. A. (2006). Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 20, 1218-1249. Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003). Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4, 437-450. Hollstein, M., Shomer, B., Greenblatt, M., Soussi, T., Hovig, E., Montesano, R., and Harris, C. C. (1996). Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation. Nucleic Acids Res 24, 141-146. Hruban, R. H., Goggins, M., Parsons, J., and Kern, S. E. (2000). Progression model for pancreatic cancer. Clin Cancer Res 6, 2969-2972. Hruban, R. H., Iacobuzio-Donahue, C., Wilentz, R. E., Goggins, M., and Kern, S. E. (2001). Molecular pathology of pancreatic cancer. Cancer J 7, 251-258. Hruban, R. H., Petersen, G. M., Ha, P. K., and Kern, S. E. (1998). Genetics of pancreatic cancer. From genes to families. Surg Oncol Clin N Am 7, 1-23. Hruban, R. H., van Mansfeld, A. D., Offerhaus, G. J., van Weering, D. H., Allison, D. C., Goodman, S. N., Kensler, T. W., Bose, K. K., Cameron, J. L., and Bos, J. L. (1993). K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 143, 545-554. Hu, Y. X., Watanabe, H., Ohtsubo, K., Yamaguchi, Y., Ha, A., Okai, T., and Sawabu, N. (1997). Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma. Clin Cancer Res 3, 1473-1477. Hurst, R. D., Azam, S., Hurst, A., and Clark, J. B. (2001). Nitric-oxide-induced inhibition of glyceraldehyde-3-phosphate dehydrogenase may mediate reduced endothelial cell monolayer integrity in an in vitro model blood-brain barrier. Brain Res 894, 181-188. Ishitani, R., Tanaka, M., Sunaga, K., Katsube, N., and Chuang, D. M. (1998). Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. Mol Pharmacol 53, 701-707. Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., and Thun, M. J. (2007). Cancer statistics, 2007. CA Cancer J Clin 57, 43-66. Kannan, K., and Jain, S. K. (2000). Oxidative stress and apoptosis. Pathophysiology 7, 153-163. Kato, M., Sakai, K., and Endo, A. (1992). Koningic acid (heptelidic acid) inhibition of glyceraldehyde-3-phosphate dehydrogenases from various sources. Biochim Biophys Acta 1120, 113-116. Keelan, J., Allen, N. J., Antcliffe, D., Pal, S., and Duchen, M. R. (2001). Quantitative imaging of glutathione in hippocampal neurons and glia in culture using monochlorobimane. J Neurosci Res 66, 873-884. Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-257. Kim, J. S., Qian, T., and Lemasters, J. J. (2003). Mitochondrial permeability transition in the switch from necrotic to apoptotic cell death in ischemic rat hepatocytes. Gastroenterology 124, 494-503. Klimstra, D. S., and Longnecker, D. S. (1994). K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol 145, 1547-1550. Knap, A. K., and Pratt, R. F. (1991). Inactivation of the RTEM-1 cysteine beta-lactamase by iodoacetate. The nature of active-site functional groups and comparisons with the native enzyme. Biochem J 273(Pt 1), 85-91. Korsmeyer, S. J., Wei, M. C., Saito, M., Weiler, S., Oh, K. J., and Schlesinger, P. H. (2000). Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 7, 1166-1173. Kosower, N. S., and Kosower, E. M. (1987). Thiol labeling with bromobimanes. Methods Enzymol 143, 76-84. Kroemer, G., and Reed, J. C. (2000). Mitochondrial control of cell death. Nat Med 6, 513-519. Leist, M., and Jaattela, M. (2001). Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2, 589-598. Leist, M., Single, B., Castoldi, A. F., Kuhnle, S., and Nicotera, P. (1997). Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185, 1481-1486. Lemasters, J. J., DiGuiseppi, J., Nieminen, A. L., and Herman, B. (1987). Blebbing, free Ca2+ and mitochondrial membrane potential preceding cell death in hepatocytes. Nature 325, 78-81. Lev-Ari, S., Vexler, A., Starr, A., Ashkenazy-Voghera, M., Greif, J., Aderka, D., and Ben-Yosef, R. (2007). Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Invest 25, 411-418. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. (1996). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147-157. Liu, X., Wang, J., Sun, B., Zhang, Y., Zhu, J., and Li, C. (2007). Cell growth inhibition, G2M cell cycle arrest, and apoptosis induced by the novel compound Alternol in human gastric carcinoma cell line MGC803. Invest New Drugs 25, 505-517. Lorenzo, H. K., Susin, S. A., Penninger, J., and Kroemer, G. (1999). Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Differ 6, 516-524. Lowe, S. W. (1995). Cancer therapy and p53. Curr Opin Oncol 7, 547-553. Maitra, A., Adsay, N. V., Argani, P., Iacobuzio-Donahue, C., De Marzo, A., Cameron, J. L., Yeo, C. J., and Hruban, R. H. (2003). Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol 16, 902-912. Malcolm, C. S., Benwell, K. R., Lamb, H., Bebbington, D., and Porter, R. H. (2000). Characterization of iodoacetate-mediated neurotoxicity in vitro using primary cultures of rat cerebellar granule cells. Free Radic Biol Med 28, 102-107. Malumbres, M., and Barbacid, M. (2003). RAS oncogenes: the first 30 years. Nat Rev Cancer 3, 459-465. Matrisian, L. M., Rautmann, G., Magun, B. E., and Breathnach, R. (1985). Epidermal growth factor or serum stimulation of rat fibroblasts induces an elevation in mRNA levels for lactate dehydrogenase and other glycolytic enzymes. Nucleic Acids Res 13, 711-726. Matthews, R. T., Ferrante, R. J., Jenkins, B. G., Browne, S. E., Goetz, K., Berger, S., Chen, I. Y., and Beal, M. F. (1997). Iodoacetate produces striatal excitotoxic lesions. J Neurochem 69, 285-289. Mazzola, J. L., and Sirover, M. A. (2002). Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders? Neurotoxicology 23, 603-609. Meldrum, D. R. (1998). Tumor necrosis factor in the heart. Am J Physiol 274, R577-595. Michaud, D. S., Giovannucci, E., Willett, W. C., Colditz, G. A., Stampfer, M. J., and Fuchs, C. S. (2001). Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 286, 921-929. Mikuriya, K., Kuramitsu, Y., Ryozawa, S., Fujimoto, M., Mori, S., Oka, M., Hamano, K., Okita, K., Sakaida, I., and Nakamura, K. (2007). Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. Int J Oncol 30, 849-855. Millis, K. K., Lesko, S. A., and Gamcsik, M. P. (1997). Formation, intracellular distribution and efflux of glutathione-bimane conjugates in drug-sensitive and -resistant MCF-7 cells. Cancer Chemother Pharmacol 40, 101-111. Moldeus, P., Cotgreave, I. A., and Berggren, M. (1986). Lung protection by a thiol-containing antioxidant: N-acetylcysteine. Respiration 50 Suppl 1, 31-42. Morgenegg, G., Winkler, G. C., Hubscher, U., Heizmann, C. W., Mous, J., and Kuenzle, C. C. (1986). Glyceraldehyde-3-phosphate dehydrogenase is a nonhistone protein and a possible activator of transcription in neurons. J Neurochem 47, 54-62. Nagy, E., and Rigby, W. F. (1995). Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold). J Biol Chem 270, 2755-2763. Nakamura, H., Nakamura, K., and Yodoi, J. (1997). Redox regulation of cellular activation. Annu Rev Immunol 15, 351-369. Naumann, M., Savitskaia, N., Eilert, C., Schramm, A., Kalthoff, H., and Schmiegel, W. (1996). Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors. Gastroenterology 110, 1215-1224. Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F., and Riccardi, C. (1991). A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139, 271-279. Nicotera, P., Leist, M., and Ferrando-May, E. (1998). Intracellular ATP, a switch in the decision between apoptosis and necrosis. Toxicol Lett 102-103, 139-142. Parkin, D. M., Bray, F. I., and Devesa, S. S. (2001). Cancer burden in the year 2000. The global picture. Eur J Cancer 37 Suppl 8, S4-66. Petersen, G. M., and Hruban, R. H. (2003). Familial pancreatic cancer: where are we in 2003? J Natl Cancer Inst 95, 180-181. Richter, C., Schweizer, M., Cossarizza, A., and Franceschi, C. (1996). Control of apoptosis by the cellular ATP level. FEBS Lett 378, 107-110. Riordan, J. T., Muthaiyan, A., Van Voorhies, W., Price, C. T., Graham, J. E., Wilkinson, B. J., and Gustafson, J. E. (2007). Response of Staphylococcus aureus to salicylate challenge. J Bacteriol 189, 220-227. Rondinelli, R. H., Epner, D. E., and Tricoli, J. V. (1997). Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in late pathological stage human prostate cancer. Prostate Cancer Prostatic Dis 1, 66-72. Rozenblum, E., Schutte, M., Goggins, M., Hahn, S. A., Panzer, S., Zahurak, M., Goodman, S. N., Sohn, T. A., Hruban, R. H., Yeo, C. J., and Kern, S. E. (1997). Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res 57, 1731-1734. Rutherford, A., and Chung, R. T. (2008). Acute liver failure: mechanisms of hepatocyte injury and regeneration. Semin Liver Dis 28, 167-174. Sabri, M. I., and Ochs, S. (1971). Inhibition of glyceraldehyde-3-phosphate dehydrogenase in mammalian nerve by iodoacetic acid. J Neurochem 18, 1509-1514. Sakai, K., Hasumi, K., and Endo, A. (1990). Two glyceraldehyde-3-phosphate dehydrogenase isozymes from the koningic acid (heptelidic acid) producer Trichoderma koningii. Eur J Biochem 193, 195-202. Sakai, K., Hasumi, K., and Endo, A. (1991). Identification of koningic acid (heptelidic acid)-modified site in rabbit muscle glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1077, 192-196. Sakamoto, T., Repasky, W. T., Uchida, K., Hirata, A., and Hirata, F. (1996). Modulation of cell death pathways to apoptosis and necrosis of H2O2-treated rat thymocytes by lipocortin I. Biochem Biophys Res Commun 220, 643-647. Sakurai, K., and Cederbaum, A. I. (1998). Oxidative stress and cytotoxicity induced by ferric-nitrilotriacetate in HepG2 cells that express cytochrome P450 2E1. Mol Pharmacol 54, 1024-1035. Saunders, P. A., Chalecka-Franaszek, E., and Chuang, D. M. (1997). Subcellular distribution of glyceraldehyde-3-phosphate dehydrogenase in cerebellar granule cells undergoing cytosine arabinoside-induced apoptosis. J Neurochem 69, 1820-1828. Sawa, A., Khan, A. A., Hester, L. D., and Snyder, S. H. (1997). Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. Proc Natl Acad Sci U S A 94, 11669-11674. Schek, N., Hall, B. L., and Finn, O. J. (1988). Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in human pancreatic adenocarcinoma. Cancer Res 48, 6354-6359. Schenk, M., Schwartz, A. G., O'Neal, E., Kinnard, M., Greenson, J. K., Fryzek, J. P., Ying, G. S., and Garabrant, D. H. (2001). Familial risk of pancreatic cancer. J Natl Cancer Inst 93, 640-644. Schultz, D. E., Hardin, C. C., and Lemon, S. M. (1996). Specific interaction of glyceraldehyde 3-phosphate dehydrogenase with the 5'-nontranslated RNA of hepatitis A virus. J Biol Chem 271, 14134-14142. Schulze, H., Schuler, A., Stuber, D., Dobeli, H., Langen, H., and Huber, G. (1993). Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's beta-amyloid precursor protein. J Neurochem 60, 1915-1922. Sharief, F. S., Mohler, J. L., Sharief, Y., and Li, S. S. (1994). Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues. Biochem Mol Biol Int 33, 567-574. Shih, C., and Weinberg, R. A. (1982). Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell 29, 161-169. Simon, H. U., Haj-Yehia, A., and Levi-Schaffer, F. (2000). Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415-418. Singh, R., and Green, M. R. (1993). Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science 259, 365-368. Sirover, M. A. (1999). New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochim Biophys Acta 1432, 159-184. Sirover, M. A. (2005). New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells. J Cell Biochem 95, 45-52. Smit, V. T., Boot, A. J., Smits, A. M., Fleuren, G. J., Cornelisse, C. J., and Bos, J. L. (1988). KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res 16, 7773-7782. Stolzenberg-Solomon, R. Z., Graubard, B. I., Chari, S., Limburg, P., Taylor, P. R., Virtamo, J., and Albanes, D. (2005). Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 294, 2872-2878. Tajima, H., Tsuchiya, K., Yamada, M., Kondo, K., Katsube, N., and Ishitani, R. (1999). Over-expression of GAPDH induces apoptosis in COS-7 cells transfected with cloned GAPDH cDNAs. Neuroreport 10, 2029-2033. Tarze, A., Deniaud, A., Le Bras, M., Maillier, E., Molle, D., Larochette, N., Zamzami, N., Jan, G., Kroemer, G., and Brenner, C. (2007). GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization. Oncogene 26, 2606-2620. Tokunaga, K., Nakamura, Y., Sakata, K., Fujimori, K., Ohkubo, M., Sawada, K., and Sakiyama, S. (1987). Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 47, 5616-5619. Ublacker, G. A., Johnson, J. A., Siegel, F. L., and Mulcahy, R. T. (1991). Influence of glutathione S-transferases on cellular glutathione determination by flow cytometry using monochlorobimane. Cancer Res 51, 1783-1788. van Gurp, M., Festjens, N., van Loo, G., Saelens, X., and Vandenabeele, P. (2003). Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 304, 487-497. van Zandwijk, N. (1995). N-acetylcysteine (NAC) and glutathione (GSH): antioxidant and chemopreventive properties, with special reference to lung cancer. J Cell Biochem Suppl 22, 24-32. Verity, M. A., Torres, M., and Sarafian, T. (1991). Paradoxical potentiation by low extracellular Ca2+ of acute chemical anoxic neuronal injury in cerebellar granule cell culture. Mol Chem Neuropathol 15, 217-233. Vila, M. R., Nicolas, A., Morote, J., de, I., and Meseguer, A. (2000). Increased glyceraldehyde-3-phosphate dehydrogenase expression in renal cell carcinoma identified by RNA-based, arbitrarily primed polymerase chain reaction. Cancer 89, 152-164. Waak, J., and Dringen, R. (2006). Formation and rapid export of the monochlorobimane-glutathione conjugate in cultured rat astrocytes. Neurochem Res 31, 1409-1416. Warburg, O. (1956). On the origin of cancer cells. Science 123, 309-314. Warshaw, A. L., and Fernandez-del Castillo, C. (1992). Pancreatic carcinoma. N Engl J Med 326, 455-465. Webb, J. L. (1950). The actions of metabolic substrates and inhibitors on the rabbit auricle. Br J Pharmacol Chemother 5, 87-117. Webb, J. L., Saunders, P. R., and Thienes, C. H. (1949). The metabolism of the heart in relation to drug action; the action of metabolic inhibitors on rat heart slice respiration. Arch Biochem 22, 458-466. Wilson, M. R. (1998). Apoptosis: unmasking the executioner. Cell Death Differ 5, 646-652. Wolf, M. B., and Baynes, J. W. (2006). The anti-cancer drug, doxorubicin, causes oxidant stress-induced endothelial dysfunction. Biochim Biophys Acta 1760, 267-271. Wu, G., Chai, J., Suber, T. L., Wu, J. W., Du, C., Wang, X., and Shi, Y. (2000). Structural basis of IAP recognition by Smac/DIABLO. Nature 408, 1008-1012. Yamaguchi, H., Bhalla, K., and Wang, H. G. (2003). Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria. Cancer Res 63, 1483-1489. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/37345 | - |
| dc.description.abstract | 胰臟癌在臺灣是十大癌症死因之一。胰臟癌患者的平均存活時間只有四至六個月，並且整體的五年存活率小於百分之五。百分之八十五的胰臟癌在診斷確立時，已有遠處轉移或局部侵襲至臨近器官，此時只有少於百分之十能夠接受根除性手術治療，因此尋找更有效的藥物治療而且能改善存活率對於胰臟癌病人似乎是必要且急需的。GAPDH這個基因長久以來都被視為細胞內一種穩定表現的基因(Housekeeping gene)。到近幾年來，許多報導都指出在不同的腫瘤細胞快速生長過程中GAPDH mRNA往往有比較高表現量，甚至有研究認為GAPDH對於癌症的抗藥性扮演重要的地位。因此本篇論文則希望能夠藉由抑制GAPDH活性來達到對人類胰臟癌有更好的療效。碘乙酸 ( Iodoacetic acid，IAA ) 可以作為GAPDH的抑制劑。因為IAA會在蛋白質的Cysteine的Thiol group作Carboxymethylation而使酵素失去功能。本實驗將IAA作用於人類胰臟癌細胞株(MIA PaCa-2 and Panc-1)，發現IAA和細胞凋亡的相關機制有關。從我們的結果顯示當IAA作用於人類胰臟癌細胞時，在Annexin V、Cytochrome C release、Caspase活化、及Hoechst染色觀察到細胞凋亡特徵。在ATP含量測量以及PI染色等實驗發現這樣死亡方式可能牽涉到Secondary necrosis之機制。為了更進一步了解IAA如何造成細胞凋亡原因，我們先在外加抗氧化劑NAC及還原劑DTT等實驗中看到NAC及DTT都可降低IAA所造成的細胞傷害。接著在Monochlorobimane ( MCB )螢光染色發現IAA引起細胞內GSH含量減少，加上許多文獻指出GSH減少與細胞內ROS產生是有關聯性的，因此在活細胞雷射掃描共軛焦顯微鏡以MitoSox染劑觀察細胞質中([O2•-]i)的變化，結果顯示IAA會誘發細胞內自由基([O2.-]i)含量上升。根據這些實驗結果我們推測IAA處理可能會引發細胞內ROS上升，細胞內氧化還原機制不平衡，同時細胞內的ATP來源受到阻礙，以致細胞內能量下降進而產生細胞凋亡及Secondary necrosis現象。 | zh_TW |
| dc.description.abstract | Pancreatic cancer is one of the tenth leading causes of death in Taiwan. The average survival duration for the patients with pancreatic cancer is about 4–6 months, and the overall 5-year survival rate is less than 5%. There are more than 85% of pancreatic cancers metastasized or extended locally at the time of diagnosis. Finally, there were less than 10% of the pancreatic cancer patients able to undergo curative resection. An effective treatment or novel agent for this devastating disease is urgently needed. Recent studies indicate that the cellular function of GAPDH (Glyceraldehyde-3-Phosphate Dehydrogenase) could be involved in not only part of glycolysis, but also in novel signal pathways, especially in cancer cell survival of drug resistence. Moreover, there is static result show that the mRNA and protein expression of GAPDH in pancreatic adenocarcinoma is significant higher than in normal pancreas tissue. It would be of interest to study possible role of GAPDH in pancreatic cancer cells. There is ample evidence shows that iodoacetic acid (IAA) acts as an inhibitor of GAPDH because of its carboxymethylating ability on cysteine, an activate site of GAPDH. Human pancreatic cell lines (MIA PaCa-2 and Panc-1) were used, and we have found that IAA suppressed cancer cells viability and caused apoptotic cell death. These apoptotic signatures include phosphatidylserine exposure, cytochrome C release, activated caspases, and nuclear condensation. Nonetheless, we also consider that IAA-induced apoptosis would involve secondary necrotic cell death, according to our results of ATP decrease and propidium iodide (+) staining. Furthermore, we found that N-acetyl-L cysteine (NAC) and dithiothreitol (DTT) could attenuate the IAA-induced cellular damage. Results of glutathione (GSH) decline and accumulation of superoxide anion indicate that IAA could lead to imbalanced reduction-oxidation state of the cell, and then cause cell death. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-13T15:25:04Z (GMT). No. of bitstreams: 1 ntu-97-R95441001-1.pdf: 1649442 bytes, checksum: 6dffb2e6116c4fdc5a026716daa8961d (MD5) Previous issue date: 2008 | en |
| dc.description.tableofcontents | 圖表次…………………………………………………Ⅲ
中文摘要………………………………………………Ⅴ 英文摘要………………………………………………Ⅶ 緒論……………………………………………………1 材料與方法……………………………………………14 結果……………………………………………………24 討論……………………………………………………33 結論與展望……………………………………………40 圖表……………………………………………………41 附錄……………………………………………………62 參考文獻………………………………………………65 | |
| dc.language.iso | zh-TW | |
| dc.subject | 細胞凋亡 | zh_TW |
| dc.subject | 碘乙酸 | zh_TW |
| dc.subject | 人類胰臟癌細胞 | zh_TW |
| dc.subject | apoptosis | en |
| dc.subject | Iodoacetic acid | en |
| dc.subject | Human pancreatic cancer | en |
| dc.title | 碘乙酸( Iodoacetic acid )於人類胰臟癌細胞造成細胞凋亡機制之探討 | zh_TW |
| dc.title | The Mechanism of Iodoacetic Acid Induced Apoptosis in Human Pancreatic Caner Cells | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 96-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 胡孟君,俞松良 | |
| dc.subject.keyword | 人類胰臟癌細胞,碘乙酸,細胞凋亡, | zh_TW |
| dc.subject.keyword | Human pancreatic cancer,Iodoacetic acid,apoptosis, | en |
| dc.relation.page | 80 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2008-07-21 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 生理學研究所 | zh_TW |
| 顯示於系所單位： | 生理學科所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-97-1.pdf 未授權公開取用 | 1.61 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。